Learn more

ONCODESIGN SA

Overview
  • Total Patents
    78
  • GoodIP Patent Rank
    22,307
  • Filing trend
    ⇩ 88.0%
About

ONCODESIGN SA has a total of 78 patent applications. It decreased the IP activity by 88.0%. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are CHEMBRIDGE CORP, NANTBIOSCIENCE INC and PHENEX PHARMACEUTICALS AG.

Patent filings per year

Chart showing ONCODESIGN SAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Hoflack Jan Marie Cyriel Jozef 37
#2 Hoflack Jan 24
#3 Blom Petra Marcella Francoise 24
#4 Blom Petra 23
#5 Gomez Sylvie 13
#6 Blom Petra Marcella Françoise 13
#7 Benderitter Pascal 12
#8 Lavergne Olivier 11
#9 Benderitter Pascal Andre Rene 11
#10 Benderitter Pascal André René 10

Latest patents

Publication Filing date Title
WO2017148925A1 Radiolabeled macrocyclic egfr inhibitor
WO2016146651A1 Macrocyclic activin-like receptor kinase inhibitors
CA2958782A1 Macrocyclic rip2 kinase inhibitors
WO2016042089A1 Macrocyclic lrrk2 kinase inhibitors
WO2015136073A1 Macrocyclic tgf-br2 kinase inhibitors
GB201404570D0 Macrocyclic kinase inhibitors
EP2968325A1 Macrocyclic rip2 kinase inhibitors
GB201404555D0 Macrocyclic kinase inhibitors
CA2906257A1 Macrocyclic rip2 kinase inhibitors
BR112015022650A2 macrocyclic salt inducible kinase inhibitors.
EP2968326A1 Macrocyclic salt-inducible kinase inhibitors
GB201304714D0 Macrocyclic RIP2 Kinase inhibitors
EP2760867A1 Macrocyclic flt3 kinase inhibitors
CN103930427A Macrocyclic FLT3 kinase inhibitors